Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
Submitted by
admin
on December 8, 2023 - 9:56am
Source:
Motley Fool
News Tags:
Eli Lilly
Novo Nordisk
weight loss
Wegovy
Zepbound
Headline:
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
snippet:
Novo Nordisk was first to market with its blockbuster weight loss treatment Wegovy.
Doctors have prescribed Eli Lilly’s diabetes treatment for weight loss. Now regulators have officially given the nod to the treatment for the weight loss indication.
Do Not Allow Advertisers to Use My Personal information